研究概要
免疫抑制性IL-10+ TAMs促成了免疫效应细胞功能失活和免疫检查点表达升高的免疫逃逸微环境,因此,尽管对ACT反应较好,仍预示不良临床结局。IL-10+ TAMs可能为EGFR靶向治疗、FGFR3靶向治疗以及免疫治疗的个体化选择提供指导。免疫抑制性IL-10+ TAMs作为治疗靶点的潜力值得进一步探索。
研究思路结论见上方概要
背景
肿瘤相关巨噬细胞(TAMs)分泌 IL-10 可能是一种具有独特极化状态和抑制抗肿瘤免疫应答功能的功能性细胞亚群。在此,我们评估了临床结局、治疗反应和分子特征与 IL-10+ TAMs 浸润的关联,以及 IL-10+ TAMs 对肌层浸润性膀胱癌(MIBC)免疫微环境的潜在影响。
方法
在这项回顾性研究中,分别纳入了128例和391例来自中山医院(ZS队列)和癌症基因组图谱队列的MIBC患者。在ZS队列中进行了免疫组化以量化各种免疫细胞浸润。进行了单细胞RNA测序和流式细胞术以检查IL-10 + TAMs的功能状态及其与其他免疫细胞的相关性。还进行了生存分析和辅助化疗(ACT)获益评估分析。
结果
高 IL-10 + TAMs 浸润与 MIBC 中总生存期和无复发生存期的不良预后相关,但与更优的化疗反应相关。具有抑制性特征的 IL-10 + TAMs 与免疫逃逸性肿瘤微环境相关,其特征为 CD8 + T 细胞耗竭、NK 细胞不成熟以及免疫检查点表达增加。此外,高 IL-10 + TAMs 浸润与基底样亚型及 EGF 信号增强密切相关。
展开英文摘要原文
BACKGROUND: Tumor-associated macrophages (TAMs) secreting IL-10 could be a specific functional cell subset with distinct polarization state and suppressive role in antitumor immune response. Here, we assessed the associations of clinical outcome, therapeutic responses and molecular features with IL-10 + TAMs infiltration, and potential impact of IL-10 + TAMs on the immune contexture in muscle-invasive bladder cancer (MIBC).
METHODS: In this retrospective study, 128 patients and 391 patients with MIBC from Zhongshan hospital (ZS cohort) and The Cancer Genome Atlas cohort were included respectively. Immunohistochemistry was performed to quantify various immune cell infiltration in the ZS cohort. Single cell RNA sequencing and flow cytometry were performed to examine the functional status of IL-10 + TAMs and its correlation with other immune cells. Survival analyses and assessment of the adjuvant chemotherapy (ACT) benefit analyses were also performed.
RESULTS: High IL-10 + TAMs infiltration was associated with inferior prognosis in terms of overall survival and recurrence-free survival, but superior chemotherapeutic response in MIBC. IL-10 + TAMs with suppressive features were associated with immunoevasive tumor microenviroment characterized by exhausted CD8 + T cells, immature NK cells and increased immune checkpoint expression. Additionally, high IL-10 + TAMs infiltration showed a strong linkage with basal-featured subtype and augmented EGF signaling.
CONCLUSIONS: Immunosuppresive IL-10 + TAMs contributed to an evasive contexture with incapacitated immune effector cells and increased immune checkpoint expression, therefore, predicting unfavorable clinical outcomes despite better ACT responsiveness. IL-10 + TAMs might provide guidance for customized selection of EGFR-targeted therapy, FGFR3-targeted therapy as well as immunotherapy. The potential of immunosuppressive IL-10 + TAMs as a therapeutic target is worth further exploration.
论文信息
- 作者
- Xu Y、Zeng H、Jin K、Liu Z、Zhu Y、Xu L、Wang Z、Chang Y
- 第一作者单位
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.China
- 通讯作者单位
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China zwwang12@fudan.edu.cn changyuan0802@163.com jjxufdu@fudan.edu.cn.China
- 文献类型
- 非美国政府资助研究
- 期刊
- Journal for immunotherapy of cancer2022 Mar